Krka, d.d., Novo Mesto
KRKG · LJSE · Pharmaceuticals
About the company
Krka is a Slovenian generic pharmaceutical company headquartered in Novo Mesto, ranked among the top 10 generic drug makers in Europe and 16th globally. The group generates revenues primarily from prescription generics, over-the-counter medicines, and veterinary products, with Eastern Europe representing its largest regional market. In 2024, group revenue reached approximately €1.9 billion, up 6% year-on-year, with a record operating profit of €408 million.
| Exchange | LJSE |
| Ticker | KRKG |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $4.42B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (LJSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Ljubljana Stock Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Slovenia
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.